These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2014007)

  • 1. Genetic destabilization of Candida albicans by hydroxyurea.
    Sarachek A; Henderson LA; Eddy KB
    Microbios; 1991; 65(262):39-61. PubMed ID: 2014007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the genotoxic spectrum of cisplatin for Candida albicans.
    Sarachek A; Henderson L; Wilkens WE
    Microbios; 1992; 72(292-293):183-201. PubMed ID: 1488020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinagenicity of caffeine for Candida albicans.
    Sarachek A; Henderson LA
    Mycopathologia; 1990 May; 110(2):63-76. PubMed ID: 2195351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations for susceptibilities to ultraviolet induced cellular inactivation and gene segregation among protoplast fusion hybrids of Candida albicans.
    Sarachek A; Henderson LA
    Cytobios; 1988; 55(222-223):171-84. PubMed ID: 3075166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle arrest during S or M phase generates polarized growth via distinct signals in Candida albicans.
    Bachewich C; Nantel A; Whiteway M
    Mol Microbiol; 2005 Aug; 57(4):942-59. PubMed ID: 16091036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans MTLalpha tup1Delta mutants can reversibly switch to mating-competent, filamentous growth forms.
    Park YN; Morschhäuser J
    Mol Microbiol; 2005 Dec; 58(5):1288-302. PubMed ID: 16313617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of high frequency switching in the yeast Candida albicans and the slime mold Dictyostelium discoideum.
    Soll DR; Kraft B
    Dev Genet; 1988; 9(4-5):615-28. PubMed ID: 3072134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response of several Candida albicans strains to inhibitory concentrations of heavy metals.
    Malavasic MJ; Cihlar RL
    J Med Vet Mycol; 1992; 30(6):421-32. PubMed ID: 1287161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans switch phenotypes display differential levels of fitness.
    Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
    Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in commensal isolates of the asexual diploid yeast Candida albicans.
    Diogo D; Bouchier C; d'Enfert C; Bougnoux ME
    Fungal Genet Biol; 2009 Feb; 46(2):159-68. PubMed ID: 19059493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK.
    Payne S; Gibson G; Wynne A; Hudspith B; Brostoff J; Tuohy K
    Curr Issues Intest Microbiol; 2003 Mar; 4(1):1-8. PubMed ID: 12691257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
    Park YN; Morschhäuser J
    Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J; Doyle S; Kavanagh K
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
    Maynard K; Parsons PG
    Cancer Res; 1986 Oct; 46(10):5009-13. PubMed ID: 3756862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of growth conditions on Candida albicans adhesion, hydrophobicity and cell wall ultrastructure.
    Kennedy MJ; Sandin RL
    J Med Vet Mycol; 1988 Apr; 26(2):79-92. PubMed ID: 3047356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans.
    Fekete A; Emri T; Gyetvai A; Gazdag Z; Pesti M; Varga Z; Balla J; Cserháti C; Emody L; Gergely L; Pócsi I
    FEMS Yeast Res; 2007 Sep; 7(6):834-47. PubMed ID: 17498215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic variation in C. albicans.
    Wickes BL; Petter R
    Curr Top Med Mycol; 1996 Dec; 7(1):71-86. PubMed ID: 9504060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.